CSL TETANUS IMMUNOGLOBULIN VF (human) 250IU injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

csl tetanus immunoglobulin vf (human) 250iu injection vial

csl behring australia pty ltd - tetanus immunoglobulin, quantity: 250 iu; human immunoglobulin g, quantity: 160 mg/ml - injection, solution - excipient ingredients: glycine; human immunoglobulin a - tetanus immunoglobulin is indicated for the passive protection of individuals who have sustained a tetanus-prone wound and who have either not been actively immunised against tetanus or whose immunisation history is doubtful. it should also be given to the fully immunised patient with a tetanus-prone wound if more than 10 years have elapsed since the last dose of toxoid. in all the above instances, active immunisation with tetanus toxoid, adsorbed or adt vaccine should be commenced at the same time [in accordance with details specified in table 1 (guide to tetanus prophylaxis in wound management) in indication section of the approved product information provided as attachment 1]. although tetanus immunoglobulin and vaccine should be given at the same time, they should be administered in opposite limbs, using separate syringes.

SEA SNAKE ANTIVENOM (equine) 1000U injection  vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

sea snake antivenom (equine) 1000u injection vial

seqirus pty ltd - sea snake antivenom, quantity: 1000 u - injection, concentrated - excipient ingredients: phenol; sodium chloride; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a sea snake.

TAIPAN ANTIVENOM (equine) 12000U injection    vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

taipan antivenom (equine) 12000u injection vial

seqirus pty ltd - taipan antivenom, quantity: 12000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a taipan.

DEATH ADDER ANTIVENOM (equine) 6000U injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

death adder antivenom (equine) 6000u injection vial

seqirus pty ltd - death adder antivenom, quantity: 6000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a death adder.

TIGER SNAKE ANTIVENOM (equine) 3000U          injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

tiger snake antivenom (equine) 3000u injection vial

seqirus pty ltd - tiger snake antivenom, quantity: 3000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite of a tiger, copperhead or black snake.

BLACK SNAKE ANTIVENOM (equine) 18000U injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

black snake antivenom (equine) 18000u injection vial

seqirus pty ltd - black snake antivenom, quantity: 18000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a king brown or mulga snake. although the antivenom is effective in the management of patients who are bitten by other members of the genus pseudechis, including the red-bellied or common black snake, tiger snake antivenom is the preferred treatment.

CSL Rh(D) IMMUNOGLOBULIN VF (human) 250 IU injection vial Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

csl rh(d) immunoglobulin vf (human) 250 iu injection vial

csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 250 iu; anti-d rho immunoglobulin, quantity: 10 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - rh(d) immunoglobulin is indicated for the prevention of rh sensitisation in rh(d)negative females at or below child bearing age.

RABIPUR rabies virus vaccine (Inactivated) 2.5 IU powder for injection vial with diluent pre-filled syringe Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

rabipur rabies virus vaccine (inactivated) 2.5 iu powder for injection vial with diluent pre-filled syringe

seqirus pty ltd - rabies virus, quantity: 2.5 iu - injection, powder for - excipient ingredients: monopotassium glutamate; trometamol; sodium chloride; disodium edetate; polygeline; sucrose - active immunisation against rabies virus, including a) pre-exposure immunisation b) post-exposure treatment following exposure to rabies virus.

HyperRAB Solution for Infiltration & Intramuscular Injection Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

hyperrab solution for infiltration & intramuscular injection

grifols asia pacific pte. ltd. - rabies immune globulin (human) - injection - 150 iu/ml - rabies immune globulin (human) 300 iu/ml